Loading organizations...
Key people at Heights Capital Management.
Heights Capital Management is an investment firm specializing in private investments in public equity (PIPE). The firm strategically deploys capital into emerging growth companies across diverse sectors like biotechnology, technology, and financial services. This approach identifies and supports businesses with significant growth potential by providing private capital within public market structures.
Established in San Francisco, California, Heights Capital Management was founded in 1996. Its genesis stemmed from an insight into combining private funding with public market accessibility for high-growth ventures. While specific founders remain private, the firm's affiliation with Susquehanna International Group (SIG) underpins its sophisticated investment strategies and institutional lineage.
Heights Capital Management primarily serves emerging growth companies by providing crucial capital for their expansion. The firm also caters to institutional investors seeking exposure to a curated portfolio of dynamic public companies. Its long-term vision centers on continually identifying and fostering innovation within public markets, driving value through disciplined equity investments.
Key people at Heights Capital Management.
Heights Capital Management has 3 tracked investments across 3 companies. The latest tracked deal is $20.3M Series C in Alivexis in March 2022.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 3, 2022 | Alivexis | $20.3M Series C | — | Green Co Invest Investment, Jafco Ventures, Keio Innovation Initiative, Yusuke Matsumoto, Takahiro Mizumoto |
| Feb 1, 2021 | Cullgen | $50.0M Series B | 3E Bioventures Capital | MSA Capital, Octagon Capital |
| Nov 18, 2020 | MedAvail | $84.0M Other Equity | Frank YU | Adage Capital Management, Cigna Ventures, Cowen Healthcare Investments, Lewis & Clark Ventures, Maven Investment Partners, Pura Vida Investments, Redmile Group |